Scleroderma and Mitral Stenosis: a New Cardiac Involvement or an Association by Chance
Author(s) -
Ahmadreza Zarifian,
Alireza Sepehri Shamloo,
Mohammad Sobhan Sheikh Andalibi,
Hamid Hoseinkhah,
Freshteh Ghaderi,
Morteza Khaki,
Aliasghar Moeinipour
Publication year - 2016
Publication title -
international cardiovascular forum journal
Language(s) - English
Resource type - Journals
eISSN - 2410-2636
pISSN - 2409-3424
DOI - 10.17987/icfj.v8i0.261
Subject(s) - medicine , scleroderma (fungus) , cardiology , etiology , stenosis , systemic scleroderma , valvular heart disease , mitral valve , heart failure , disease , surgery , pathology , inoculation
Systemic Sclerosis (SSc) is an autoimmune disorder with unknown etiology, which presents with vascular lesions and fibrosis of the skin and internal organs. Cardiac, renal, and pulmonary involvements are major causes of death in systemic sclerosis. Although a major cause of scleroderma deaths is cardiac failure, scleroderma rarely causes valvular disease. This is the eighth global report on scleroderma in company with mitral stenosis and the first one in Iran. Case report: The patient was a 48-year-old woman with severe mitral stenosis who was diagnosed with scleroderma 6 months before. Echocardiographic assessments had revealed no clinical manifestation of heart involvement in her previous visits. We used cardiac surgical treatment with successful outcome. Conclusion: The present case conrms the data from the currently available literature, indicating that mitral valve involvement in systemic sclerosis is a rare occurrence. Awareness of this uncommon association and adequate management to prevent complications of the underlying disease are prerequisites for successful mitral valve repair or replacement in such patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom